53233-87-7

Usage

Uses

Used in Organic Synthesis:
7-methyl-1H-indol-5-ol is used as a key intermediate in the synthesis of various organic compounds due to its reactive functional groups and structural features.
Used in Pharmaceutical Industry:
7-methyl-1H-indol-5-ol is used as a building block for the development of new pharmaceuticals, leveraging its potential biological activity and chemical reactivity to create novel drug candidates.
Used in Agrochemical Industry:
7-methyl-1H-indol-5-ol is employed as a precursor in the synthesis of agrochemicals, contributing to the development of new pesticides or other agricultural chemicals.
Used in Natural Product Synthesis:
7-methyl-1H-indol-5-ol is utilized as a starting material for the synthesis of natural products, taking advantage of its structural similarity to certain natural compounds to facilitate the production of bioactive molecules.
Used in Medicine and Drug Discovery:
7-methyl-1H-indol-5-ol is used as a research tool in the field of medicine and drug discovery, where its potential biological activity is explored for the development of new therapeutic agents.

Upstream product

• 65673-86-1 2,3-dihydro-7-methylindole 

Downstream Products

• 1022953-68-9 2,7-dimethyl-8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 

Relevant academic research and scientific papers

CHEMICAL PROCESS FOR PREPARING PHENYLPIPERIDINYL INDOLE DERIVATIVES

The present invention relates to a method of synthesizing a compound of formula (I) also referred to as 4-((2S,4S)-(4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl))benzoic acid, or a pharmaceutically acceptable salt thereof, and/or intermediates thereof, their use as pharmaceuticals and pharmaceutical compositions and the use of intermediates for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof.

2-(1H-INDOL-4-YLMETHYL)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBONITRILE DERIVATIVES AS COMPLEMENT FACTOR B INHIBITORS USEFUL FOR THE TREATMENT OF OPHTHALMIC DISEASES

The present invention provides a compound of formula (I): wherein X is N or CH, Y is NH, O or S, methods for manufacturing these compounds, and their uses as Factor B inhibitors for the treatment of conditions and diseases associated with complement alternative pathway activation such as age-related macular degeneration, diabetic retinopathy and related ophthalmic diseases. The present invention further provides pharmaceutical compositions and combinations of pharmacologically active agents.

Complement pathway modulators and uses thereof

The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.